United States · FDA National Drug Code directory

Myoview

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
17156-024_cfb49f93-c931-4429-8a04-d3c6d1e913a0
Product NDC
17156-024
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term
Tetrofosmin
Labeler
Medi-Physics Inc. dba GE Healthcare
Marketing category
NDA
Marketing start / end (source format)
19960209
Source listing expiry
20261231

Source-listed ingredients

  • TETROFOSMIN — .23 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 VIAL in 1 KIT (17156-024-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · 17156-024-05

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →